Candriam S.C.A. Rocket Pharmaceuticals, Inc. Put Options Transaction History
Candriam S.C.A.
- $15.4 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding RCKT
# of Institutions
204Shares Held
92.9MCall Options Held
341KPut Options Held
107K-
Rtw Investments, LP New York, NY17.7MShares$350 Million7.65% of portfolio
-
Wellington Management Group LLP Boston, MA9.16MShares$181 Million0.04% of portfolio
-
Black Rock Inc. New York, NY5.93MShares$117 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.37MShares$106 Million0.0% of portfolio
-
State Street Corp Boston, MA4.19MShares$82.9 Million0.01% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $1.5B
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...